Grandbrothers/iStock Editorial via Getty Images
- Eli Lilly (LLY) on Thursday announced that the U.S. FDA approved its once-weekly basal insulin product, Onswik, for adults with type 2 diabetes to be used with diet and exercise for the control of high blood sugar.
- The decision is